Telecommunications infrastructure company Lumen Technologies (NYSE:LUMN) will be reporting results this Thursday after market hours. Here’s what to expect. Lumen beat analysts’ revenue expectations by ...

Lumen stock also got a boost in the middle of the week when an analyst raised his price target on it. BNP Paribas's Sam McHugh upped his fair value assessment to $4 per share from the previous $3.51, ...

Lumen's transformation shows promise with stable revenue, earnings surprises and cost-saving initiatives. See why I maintain ...

What a brutal six months it’s been for Lumen. The stock has dropped 24.9% and now trades at $4.32, rattling many shareholders ...

See the latest Lumen Technologies Inc Ordinary Shares stock price (LUMN:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Enter Lumen, an at-home breathalyzer device that is advertised as a way to “hack” your metabolism by measuring your metabolic rate via the carbon dioxide (CO2) concentration of your breath.

Lumen's pivot to AI & fiber faces headwinds, but a potential AT&T deal offers hope. Click here to find out why I rate LUMN stock a Hold.

Lumen is a device that claims to help people better optimize their metabolism by measuring CO2 in a person’s breath to determine whether they’re burning fats or carbs.

Lumen uses patented algorithms, CO2 sensors, flow meters and other sensing technology to determine the carbon dioxide concentration in one’s breath, according to its founders.

Lumen review: Price and availability Lumen is only available as a “subscription” service through the Lumen website. You get the Lumen device for “free” along with your paid subscription.